Skip to content

The Optimal Treatment Duration for Inspiratory Muscle Strengthening Exercises in Stroke Patients

The Optimal Treatment Duration for Inspiratory Muscle Strengthening Exercises in Stroke Patients: A Double-blind Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04397133
Enrollment
54
Registered
2020-05-21
Start date
2019-12-23
Completion date
2021-04-01
Last updated
2024-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Complication, Stroke, Complication

Keywords

Breathing exercises, Cerebrovascular disease, Muscle strength, Rehabilitation, Stroke

Brief summary

The first aim of this study is if there is any difference between 4 or 8 weeks of inspiratory muscle training ( IMT ) exercises groups and control groups in stroke survivors. The secondary aims of this study is if there is any difference in walking capacity (in 8th, 12th, 24th weeks) and pulmonary complications (pneumonia incidences) in long term follow-ups (6 months) in these aforementioned groups

Detailed description

Stroke is one of the leading causes of death and disability. It is not only because of loss of extremity motions but also loss of inspiratory muscle strength. In this study we aimed to determine the optimum duration for inspiratory muscle training exercises for stroke survivors since there is not enough data about it in the literature. The study will include at least 54 patients in total and 18 in each groups ( two intervention and one control) . The patients will be evaluated for angina, chronic obstructive pulmonary disease, congestive heart disease; in these conditions the patients will be excluded from the study. Also in first examinations we will evaluate the maximal inspiratory pressure (MIP) of patients, of them the ones with MIP measurements above 80 mmH2O will also be excluded since it is the expected value in normal people. After admission and randomizing the patients, baseline measurements of MIP, 6-minutes walking test will be done. In intervention groups the patients will get 30 minutes of inspiratory muscle training exercises ( 15 minutes of two session each day) with threshold IMT device every weekday. And in control group, the patients will get sham intervention for 8 weeks. The MIP and 6-minutes walking test will be done in 8th,12th and 24th weeks. And also in 24th week we will record the pneumonia incidence if occured.

Interventions

OTHERinspiratory muscle training

inspiratory muscle training will be done with Philips Respironics Threshold IMT device starting with resistance of % 50 of MIP value

OTHERsham intervention

in these group the patients will get sham intervention with Philips Respironics Threshold IMT device

Sponsors

Istanbul Saglik Bilimleri University
CollaboratorOTHER
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

the assessor who will investigate the results and the investigator who will perform the MIP and 6-minutes walking test will be blinded to the randomization

Intervention model description

three armed study with two interventions and one control group intervention group 1: inspiratory muscle training applied for 4 week intervention group 2: inspiratory muscle training applied for 8 week control group : will get sham intervention

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Ischemic/ hemorrhagic stroke * Stroke duration\> 3 months * Age\> 18 years old * Baseline maximal inspiratory pressure below 80 cmH2O

Exclusion criteria

* Cognitive deficiency * Facial paralysis * Chronic obstructive pulmonary disease * Congestive heart disease * Myocardial infarction in last three months * Angina pectoris

Design outcomes

Primary

MeasureTime frameDescription
The change in maximal inspiratory pressureBaseline and week 8,12, 24Measured with MicroRPM (respiratory pressure meter) pressurometer device orally

Secondary

MeasureTime frameDescription
The change in walking capacityBaseline and week 8,12, 24The change in walking capacity wil be measured with Six Minute Walk Test
Pneumonia incidenceWeek 24Number of participants with Pneumonia will be determined at week 24

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026